Metabolism Score for Visceral Fat (METS-VF): A New Predictive Surrogate for CKD Risk

References

• Bikbov B, Purcell CA, Levey AS. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–733. doi:10.1016/S0140-6736(20)30045-3
   PubMed Web of Science ®Google Scholar
• Fraser SDS, Roderick PJ. Kidney disease in the Global Burden of Disease Study 2017. Nat Rev Nephrol. 2019;15(4):193–194. doi:10.1038/s41581-019-0120-0
   PubMed Web of Science ®Google Scholar
• Mu L, Liu J, Zhou G, et al. Obesity prevalence and risks among chinese adults: findings from the China PEACE million persons project, 2014–2018. Circ Cardiovasc Qual Outcomes. 2021;14(6):e007292. doi:10.1161/CIRCOUTCOMES.120.007292
   PubMed Web of Science ®Google Scholar
• Hu R, Quan S, Wang Y, et al. Spectrum of biopsy proven renal diseases in Central China: a 10-year retrospective study based on 34,630 cases. Sci Rep. 2020;10(1):10994. doi:10.1038/s41598-020-67910-w
   PubMed Web of Science ®Google Scholar
• Huang Y, Liu Y, Ma Y, et al. Associations of visceral adipose tissue, circulating protein biomarkers, and risk of cardiovascular diseases: a mendelian randomization analysis. Front Cell Dev Biol. 2022;10:840866. doi:10.3389/fcell.2022.840866
   PubMed Web of Science ®Google Scholar
• Kim S, Yi HA, Won KS, et al. Association between visceral adipose tissue metabolism and Alzheimer’s disease pathology. Metabolites. 2022;12(3):258. doi:10.3390/metabo12030258
   Web of Science ®Google Scholar
• Sun X, Han F, Miao W, et al. Sonographic evaluation of para- and perirenal fat thickness is an independent predictor of early kidney damage in obese patients. Int Urol Nephrol. 2013;45(6):1589–1595. doi:10.1007/s11255-013-0404-4
   Web of Science ®Google Scholar
• Shuster A, Patlas M, Pinthus JH, et al. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012;85(1009):1–10. doi:10.1259/bjr/38447238
   PubMed Web of Science ®Google Scholar
• Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vázquez A, et al. Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health. Clin Nutr. 2020;39(5):1613–1621. doi:10.1016/j.clnu.2019.07.012
   PubMed Web of Science ®Google Scholar
• Xing XY, Yang WY. The diagnostic significance of homeostasis model assessment of insulin resistance in metabolic syndrome among subjects with different glucose tolerance. Chin J Diabetes. 2004:12(3):182–186.
   Google Scholar
• Chinese Medical Association. Guideline for primary care of obesity: practice version (2019). Chin J Gen Pract. 2020;2:102–107.
   Google Scholar
• Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533–544. doi:10.1530/EJE-17-0883
   PubMed Web of Science ®Google Scholar
• Amato MC, Giordano C, Galia M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–922. doi:10.2337/dc09-1825
   PubMed Web of Science ®Google Scholar
• Ghaben AL, Scherer PE. Adipogenesis and metabolic health. Nat Rev Mol Cell Biol. 2019;20(4):242–258. doi:10.1038/s41580-018-0093-z
   PubMed Web of Science ®Google Scholar
• Xu X, Eales JM, Jiang X, et al. Contributions of obesity to kidney health and disease - insights from mendelian randomisation and the human kidney transcriptomics. Cardiovasc Res. 2021. doi:10.1093/cvr/cvab357
   Web of Science ®Google Scholar
• Kang Y, Huang L, Wang R, et al. Relationship between the estimated glomerular filtration rate and visceral fat thickness based on ultrasound in patients with obesity who have normal renal function without hypertension or diabetes. J Ultrasound Med. 2019;38(9):2287–2294. doi:10.1002/jum.14921
   Web of Science ®Google Scholar
• Jao TM, Nangaku M, Wu CH, et al. ATF6α downregulation of PPARα promotes lipotoxicity-induced tubulointerstitial fibrosis. Kidney Int. 2019;95(3):577–589. doi:10.1016/j.kint.2018.09.023
   PubMed Web of Science ®Google Scholar
• Tufro A. Cholesterol accumulation in podocytes: a potential novel targetable pathway in diabetic nephropathy. Diabetes. 2013;62(11):3661–3662. doi:10.2337/db13-1167
   Web of Science ®Google Scholar
• Chen N, Mu L, Yang Z, et al. Carbohydrate response element-binding protein regulates lipid metabolism via mTOR complex1 in diabetic nephropathy. J Cell Physiol. 2021;236(1):625–640. doi:10.1002/jcp.29890
   Web of Science ®Google Scholar
• Fu Z, Wu Q, Guo W, et al. Impaired insulin clearance as the initial regulator of obesity-associated hyperinsulinemia: novel insight into the underlying mechanism based on serum bile acid profiles. Diabetes Care. 2021;45(2):425–435.
   Web of Science ®Google Scholar
• Marini MA, Frontoni S, Succurro E, et al. Differences in insulin clearance between metabolically healthy and unhealthy obese subjects. Acta Diabetol. 2014;51(2):257–261. doi:10.1007/s00592-013-0511-9
   Web of Science ®Google Scholar
• Lu H, Bogdanovic E, Yu Z, et al. Combined hyperglycemia- and hyperinsulinemia-induced insulin resistance in adipocytes is associated with dual signaling defects mediated by PKC-ζ. Endocrinology. 2018;159(4):1658–1677. doi:10.1210/en.2017-00312
   Web of Science ®Google Scholar
• Liu Z, Wu KKL, Jiang X, et al. The role of adipose tissue senescence in obesity- and ageing-related metabolic disorders. Clin Sci. 2020;134(2):315–330. doi:10.1042/CS20190966
   Web of Science ®Google Scholar
• Gao Z, Daquinag AC, Fussell C, et al. Age-associated telomere attrition in adipocyte progenitors predisposes to metabolic disease. Nat Metab. 2020;2(12):1482–1497. doi:10.1038/s42255-020-00320-4
   Google Scholar
• Yoo JK, Fu Q. Impact of sex and age on metabolism, sympathetic activity, and hypertension. FASEB J. 2020;34(9):11337–11346. doi:10.1096/fj.202001006RR
   Web of Science ®Google Scholar
• Hill JL, Solomon MB, Nguyen ET, et al. Glucocorticoids regulate adipose tissue protein concentration in a depot- and sex-specific manner. Stress. 2020;23(2):243–247. doi:10.1080/10253890.2019.1658736
   PubMed Web of Science ®Google Scholar
• Tamura Y. Ectopic fat, insulin resistance and metabolic disease in non-obese Asians: investigating metabolic gradation. Endocr J. 2019;66(1):1–9. doi:10.1507/endocrj.EJ18-0435
   Web of Science ®Google Scholar
• Molina-Vega M, Castellano-Castillo D, Sánchez-Alcoholado L, et al. Relationship of zonulin with serum PCSK9 levels after a high fat load in a population of obese subjects. Biomolecules. 2020;10(5):748. doi:10.3390/biom10050748
   Web of Science ®Google Scholar
• Yang Y, Wan YP, Fan ZP, et al. Metabolically healthy obesity is associated with longitudinal changes in high-density lipoprotein cholesterol in Chinese adults. Eat Weight Disord. 2021;26(1):263–272. doi:10.1007/s40519-020-00847-1
   Web of Science ®Google Scholar
• Fang H, Berg E, Cheng X, et al. How to best assess abdominal obesity. Curr Opin Clin Nutr Metab Care. 2018;21(5):360–365. doi:10.1097/MCO.0000000000000485
   PubMed Web of Science ®Google Scholar
• Liu XZ, Chen DS, Xu X, et al. Longitudinal associations between metabolic score for visceral fat and hyperuricemia in non-obese adults. Nutr Metab Cardiovasc Dis. 2020;30(10):1751–1757. doi:10.1016/j.numecd.2020.06.001
   Web of Science ®Google Scholar
• Feng Y, Yang X, Li Y, et al. Metabolic Score for Visceral Fat: a reliable indicator of visceral obesity for predicting risk for hypertension. Nutrition. 2021;93:111443.
   Web of Science ®Google Scholar
• Feng Y, Yang X, Li Y, et al. Metabolic Score for Visceral Fat: a novel predictor for the risk of type 2 diabetes mellitus. Br J Nutr. 2021:1–8. doi:10.1017/S0007114521004116
   Web of Science ®Google Scholar
• Zhao P, Gu X, Qian D, et al. Socioeconomic disparities in abdominal obesity over the life course in China. Int J Equity Health. 2018;17(1):96. doi:10.1186/s12939-018-0809-x
   Web of Science ®Google Scholar
• Yang S, Li M, Chen Y, et al. Comparison of the correlates between body mass index, waist circumference, waist-to-height ratio, and chronic kidney disease in a rural Chinese adult population. J Renal Nutr. 2019;29(4):302–309.e301. doi:10.1053/j.jrn.2018.10.008
   Web of Science ®Google Scholar
• Memarian E, Nilsson PM, Zia I, et al. The risk of chronic kidney disease in relation to anthropometric measures of obesity: a Swedish cohort study. BMC Nephrol. 2021;22(1):330. doi:10.1186/s12882-021-02531-7
   Web of Science ®Google Scholar
• Bamba R, Okamura T, Hashimoto Y, et al. The visceral adiposity index is a predictor of incident chronic kidney disease: a population-based longitudinal study. Kidney Blood Press Res. 2020;45(3):407–418. doi:10.1159/000506461
   PubMed Web of Science ®Google Scholar
• Gu S, Wang A, Ning G, et al. Insulin resistance is associated with urinary albumin-creatinine ratio in normal weight individuals with hypertension and diabetes: the REACTION study. J Diabetes. 2020;12(5):406–416. doi:10.1111/1753-0407.13010
   Web of Science ®Google Scholar
• Hu Y, Shi LX, Zhang Q, et al. Increased risk of chronic kidney diseases in patients with metabolic syndrome: a 3-year prospective cohort study. Curr Med Sci. 2019;39(2):204–210. doi:10.1007/s11596-019-2020-8
   Web of Science ®Google Scholar